Aug 2026· Microorganisms· Vol 14, pp. 1762· 0 citations· 82 references
Medicine
TL;DR
This review summarizes the biological basis, workflow, representative advances, and limitations of self-resistance-gene guided discovery as a target-directed genome mining framework supported by tools and databases including ARTS, FunARTS, antiSMASH, and MIBiG.
Abstract
Natural products remain a major source of structurally diverse and biologically active small molecules, yet traditional activity-guided discovery is labor-intensive and prone to rediscovery, while untargeted genome mining often lacks efficient prioritization criteria for biosynthetic gene clusters (BGCs). Self-resistance-gene guided discovery has emerged as a powerful strategy to address this limitation. In producing organisms, toxic metabolites are typically accompanied by genetically encoded self-protection mechanisms, such as resistant target homologs, duplicated housekeeping genes, detoxification enzymes, repair systems, or transporters. When co-localized with BGCs, these determinants serve as functional markers for predicting bioactivity and, in some cases, molecular targets prior to compound isolation. Over the past decade, this concept has evolved into a target-directed genome mining framework supported by tools and databases including ARTS, FunARTS, antiSMASH, and MIBiG. This review summarizes the biological basis, workflow, representative advances, and limitations of this strategy. Self-resistance genes can thus be viewed as functional beacons for accelerating bioactive natural product discovery.
ABSTRACT Microbial natural products are vital for drug discovery, yet pervasive genomic fragmentation and data volume hinder the translation of metagenomic biosynthetic gene clusters (BGCs) into therapeutic leads. We present metasynBGC, a target-oriented framework that employs a “function-first” logic using experimenta...
Xiao Yang, Jia-Cheng Wu, Tao Wang et al.· Microbiology spectrum· 0 citations
This research demonstrates the efficacy of a genome-led approach to drug discovery, which has successfully translated genomic data into tangible chemical matter, functionally characterised previously cryptic BGCs, and contributed a novel class of antibiotics to the global pipeline for combating infectious diseases.
The biological relevance and evolutionary advantage of cryptic BGCs’ role in interactions between microorganisms, such as competition, communication, symbiosis and environmental adaptability, are discussed to provide a useful background for accelerating next-generation antibiotics.
Veilumuthu Pattapulavar, Sathiyabama Ramanujam, Avanthi Yellampalli et al.· Frontiers in Bioinformatics· 0 citations
Overall, this hybrid strategy effectively uncovers the antimicrobial complexity of BS4, revealing 'cryptic' peptide candidates with therapeutic potential.
Ana Paula Palacios-Rodriguez, A. Espinoza-Culupú, Joel Torres Villena et al.· Probiotics and Antimicrobial...· 0 citations
Beneficial microbes from soil or marine habitats are promising sources for discovery of new bioactive compounds for medicine and agriculture, largely through biosynthetic gene clusters (BGCs) that encode the production of complex natural products for drug and antibiotic discovery. However, most BGCs are transcription...
R. Santhoshkumar, Hafid Mohamed, M. Jemo· Frontiers in Microbiology· 0 citations
The escalating global crisis of antimicrobial resistance (AMR) poses a severe threat to human health, creating an urgent need to discover novel antimicrobial compounds. Natural products derived from actinobacteria represent a rich and diverse repertoire of bioactive molecules. However, biosynthetic gene clusters (BGCs)...
C. Jooste· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.